Aimed pharmacological treatment of Raynaud's disease.
D000328:Adult; D001593:Benzyl Compounds / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D006225:Hand; D006801:Humans; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D010069:Oxadiazoles / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010891:Piribedil / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy*; D014661:Vasoconstriction / Q000187:drug effects
D001593:Benzyl Compounds; D004983:Ethanolamines; D010069:Oxadiazoles; D010879:Piperazines; D011759:Pyrrolidines; D004088:Dihydroergotoxine; D010891:Piribedil; D005996:Nitroglycerin